124 Views

Favorite
Print

Clinical Session Proposals

EMG/Neuromuscular

Session Name: Decision Making in the Use of FDA Approved Treatments for Spinal Muscular Atrophy

4 - Review of Novel FDA Approved Treatments for Spinal Muscular Atrophy

Friday, October 21, 2022

2:00 PM – 3:15 PM ET

Location: 318-323

Speaker(s)

TC

Thomas Crawford, MD

n/a
Baltimore, Maryland

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

PDF of Slides

Dr. Crawford will review the mechanism of action of drug treatments for spinal muscular atrophy and the results from pivotal studies. Dr. Crawford will also participate in a panel discussion focused on decision making when treating an adult with spinal muscular atrophy.